Showing results (1-10 of 130) with videos related to
Sort By:
Pageof 13
Expert Review of Gastroenterology & Hepatology|July 26, 2011
Clinical and immunological features of celiac disease in patients with Type 1 diabetes mellitusUmberto Volta, Francesco Tovoli, Giacomo CaioCurrent Pharmaceutical Design|April 30, 2020
Hepatocellular Carcinoma in Non Alcoholic Fatty Liver DiseaseFrancesco Tovoli, Silvia Ferri, Fabio PiscagliaHepatic Oncology|September 8, 2018
Comparative analysis of current guidelines for the treatment of hepatocellular carcinomaFrancesco Tovoli, Giulia Negrini, Luigi BolondiVaccines|October 7, 2020
Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?Francesco Tovoli, Stefania De Lorenzo, Franco TrevisaniCancers|October 14, 2022
Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular CarcinomaStefania De Lorenzo, Francesco Tovoli, Franco TrevisaniCurrent Pharmaceutical Design|March 15, 2021
Tocilizumab: From Rheumatic Diseases to COVID-19Alberto Raiteri, Fabio Piscaglia, Alessandro Granito, et al.Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 1, 2021
Autoantibodies to speckled protein family in primary biliary cholangitisAlessandro Granito, Luigi Muratori, Francesco Tovoli, et al.Cellular & Molecular Immunology|August 13, 2013
Non-celiac gluten sensitivity: questions still to be answered despite increasing awarenessUmberto Volta, Giacomo Caio, Francesco Tovoli, et al.Expert Review of Gastroenterology & Hepatology|March 1, 2013
Gut-liver axis: an immune link between celiac disease and primary biliary cirrhosisUmberto Volta, Giacomo Caio, Francesco Tovoli, et al.BMC Gastroenterology|February 15, 2014
Effect of gluten free diet on immune response to gliadin in patients with non-celiac gluten sensitivityGiacomo Caio, Umberto Volta, Francesco Tovoli, et al.Pageof 13